To hear about similar clinical trials, please enter your email below
Trial Title:
Examination of Trends in Multiple Myeloma Trial Patient Experiences
NCT ID:
NCT05860179
Condition:
Multiple Myeloma
Conditions: Official terms:
Multiple Myeloma
Neoplasms, Plasma Cell
Conditions: Keywords:
multiple myeloma
Study type:
Observational
Overall status:
Not yet recruiting
Study design:
Time perspective:
Prospective
Summary:
Historically, participation in clinical trials has been highly skewed towards specific
demographic groups. However, research identifying which trial attributes impact
participation, in either positive or negative ways, is limited.
This study invites participants to record a wide range of data on their clinical trial
experience, with the goal being to identify factors which persistently limit patients'
ability to participate in, or complete, a trial in which they were initially interested.
Data will be analyzed through a range of demographic lenses, in hopes of discovering
patterns which might improve the experience of future multiple myeloma patients.
Criteria for eligibility:
Study pop:
Multiple myeloma patients who are actively considering enrolling in a medical trial, but
have not yet completed enrollment and randomization.
Sampling method:
Probability Sample
Criteria:
Inclusion Criteria:
- Aged ≥ 18 years old and ability to provide written informed consent obtained prior
to participation in the study and any related procedures being performed
- Patient has been diagnosed with multiple myeloma
- Subjects willing and able to comply with the protocol for the duration of the study
including undergoing treatment and scheduled visits and examination.
Exclusion Criteria:
- Inability to perform regular electronic reporting
- Patient does not understand, sign, and return consent form
- Pregnant, breastfeeding or expecting to conceive within the projected duration of
the study
Gender:
All
Minimum age:
18 Years
Maximum age:
N/A
Healthy volunteers:
No
Start date:
May 2024
Completion date:
May 2026
Lead sponsor:
Agency:
Power Life Sciences Inc.
Agency class:
Industry
Source:
Power Life Sciences Inc.
Record processing date:
ClinicalTrials.gov processed this data on November 12, 2024
Source: ClinicalTrials.gov page:
https://clinicaltrials.gov/ct2/show/NCT05860179
